Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) implanted with the Occlutech Paravalvular Leak Device (PLD) showed
long-lasting improvements in clinical
Khamidullina, Zemfira,
Avzaletdinova, Diana,
Gareeva, Diana,
Morugova, Tatyana,
Lakman, Irina,
Kopp, Kristen,
Fiedler, Lukas,
Motloch, Lukas J.,
Zagidullin, Naufal (2024) for adverse COVID-19
outcomes. The goal of study was to assess the characteristics and
outcomes.8% vs. 18.2%) and bleeding (87.5% vs. 12.5%). In the
long term the recurrence of hernias in the control
with excellent initial glycaemic control; however, whether this control is maintained in the
long term is unclear
Pang, H.-Y.,
Zhao, L.-Y,
Zhang, Z.-Q,
Galiullin, D.,
Chen, X.-L.,
Liu, K.,
Zhang, W.-H.,
Yang, K.,
Chen, X.-Z.,
Hu, J.-K. (2021) ) gastric cancer patients remain rare. The purpose of this study is to compare the perioperative and
long-termYANG, G.,
SUN, J.,
ZHANG, D.,
ZHANG, R.,
ZHONG, Y.,
WANG, X.,
CHEN, X.,
LIU, B.,
LI, L.,
ZHAO, S.,
WANG, L.,
YUAN, C.,
LONG, M.,
JIANG, H.,
LI, C.,
ZHOU, Q.,
LIAN, A.,
GAREEV, I. (2020) (ICH)
outcomes have been published. We sought to determine whether the left ventricular ejection